SARS-CoV-2 Vaccination Reduces the Frequency of Acute Kidney Disease in COVID-19 Patients: A Prospective Multicenter Multinational Study

Raúl LombardiAlejandro FerreiroJoanna Yanissa Venegas JustinianoMariana Batista PereiraM. CarlinoRolando Claure‐Del GranadoDaniela PonceMaria A. Zinoveev2026-03-222026-03-22202310.1681/asn.20233411s1712ahttps://doi.org/10.1681/asn.20233411s1712ahttps://andeanlibrary.org/handle/123456789/75183enCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakVaccinationMulticenter studyKidney diseaseCoronavirus InfectionsVirologyProspective cohort studySARS-CoV-2 Vaccination Reduces the Frequency of Acute Kidney Disease in COVID-19 Patients: A Prospective Multicenter Multinational Studyarticle